An Act relative to pharmaceutical access, costs and transparency
By Ms. Friedman, a petition (accompanied by bill, Senate, No. 749) of Cindy F. Friedman, Rebecca L. Rausch, Susannah M. Whipps, Joanne M. Comerford and other members of the General Court for legislation relative to pharmaceutical access, costs and transparency. Health Care Financing.
Bill History
| Date | Branch | Action |
|---|---|---|
| 2/16/2023 | Senate | Referred to the committee on Health Care Financing |
| 2/16/2023 | House | House concurred |
| 5/23/2023 | Joint |
|
| 6/2/2023 | Joint |
|
| 6/5/2023 | Joint | Hearing rescheduled to 06/06/2023 from 10:00 AM-04:00 PM in A-2 |
| 10/30/2023 | Senate | Accompanied a new draft, see S2492 |
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.